AnalystsLachlan BrownLachlan Brown's Stock Forecasts
AnalystsLachlan Brown
Analyst Ranking
Bottom 25%
#4177 out of 5507 analysts
Average Return
-0.47%
Win Rate
42%5 out of 12
Risk vs Reward
Poor
Good
Lachlan Brown's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ocular Therapeutix IncOCUL | +39.87% | $6.02 | $8.42 | 2025-04-08 - 2026-04-08 | Buy |
Harrow IncHROW | +15.17% | $31.17 | $35.90 | 2025-06-10 - 2026-06-10 | Buy |
Eupraxia Pharmaceuticals IncEPRX | +12.55% | $7.33 | $8.25 | 2026-03-23 - 2026-09-08 | Buy |
Cadence Design Systems IncCDNS | +11.29% | $292.50 | $325.51 | 2025-01-13 - 2026-01-12 | Strong Buy |
Synopsys IncSNPS | +9.44% | $487.43 | $533.42 | 2025-01-13 - 2026-01-12 | Strong Buy |
Lachlan Brown Analyst Color
Get additional color on Lachlan Brown's coverage of popular stocks
Lachlan Brown's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Surrozen IncSRZN | 1 | Buy | N/A | N/A | Initiates Coverage On | 20 days ago |
Sps Commerce IncSPSC | 2 | Hold | $60.00 | -24.05% | Downgrades | 5 months ago |
Descartes Systems Group IncDSGX | 2 | Strong Buy | $90.00 | +19.11% | Upgrades | 5 months ago |
Eupraxia Pharmaceuticals IncEPRX | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 months ago |
Viridian Therapeutics IncVRDN | 1 | Buy | N/A | N/A | Initiates Coverage On | 9 months ago |
Manhattan Associates IncMANH | 2 | Hold | $200.00 | N/A | Downgrades | a year ago |
Harrow IncHROW | 1 | Buy | N/A | N/A | Initiates Coverage On | a year ago |
Kalaris Therapeutics IncKLRS | 1 | Buy | N/A | N/A | Initiates Coverage On | a year ago |
Ocular Therapeutix IncOCUL | 1 | Buy | N/A | N/A | Initiates Coverage On | a year ago |
Synopsys IncSNPS | 1 | Strong Buy | $600.00 | N/A | Initiates Coverage On | 2 years ago |
Cadence Design Systems IncCDNS | 1 | Strong Buy | $350.00 | N/A | Initiates Coverage On | 2 years ago |
Apellis Pharmaceuticals IncAPLS | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.